Alchemab Therapeutics vs Bioptimus
Which Drug Discovery AI tool is better in 2026?
Alchemab Therapeutics
UK biotech using machine learning to mine patient-derived immune responses for protective
Bioptimus
Building the first universal AI foundation model for biology.
Side-by-side
Bioptimus is the more established option (raised $76M); pricing is comparable on both sides.
| Metric | Alchemab Therapeutics | Bioptimus |
|---|---|---|
| Taglinei | UK biotech using machine learning to mine patient-derived immune responses for protective | Building the first universal AI foundation model for biology. |
| Foundedi | — | 2024🏆 |
| HQi | — | Paris, FR |
| Employeesi | 11-50 | 11-50🏆 |
| Neuron scorei | 42 | 60🏆 |
| Total fundingi | $32M | $76M🏆 |
| Latest roundi | Series A | Series A · Jan 2025 |
| Valuationi | — | — |
| Cheapest paid plani | Pricing not disclosed | Pricing not disclosed |
| Free plani | ✓ | ✗ |
| Free triali | ✓ | ✗ |
| Top tier pricei | Pricing not disclosed | Pricing not disclosed |
| Pricing summaryi | Free | Enterprise · Contact sales |
| Categoriesi |
Capability matrix
Developer-facing capabilities and access signals for Alchemab Therapeutics and Bioptimus.
| Capability | Alchemab Therapeutics | Bioptimus |
|---|---|---|
| MCP support | ✗ | ✗ |
| Public API | ✗ | ✗ |
| Webhooks | ✗ | ✗ |
| OAuth 2.0 | ✗ | ✗ |
| SDK languages | — | — |
| Free plan | ✓ | ✗ |
| Free trial | ✓ | ✗ |
| Verified | ✗ | ✗ |
| Active deal | ✗ | ✗ |
🟢 Strengths of Alchemab Therapeutics
- Offers a free plan
- Offers a free trial
🔵 Strengths of Bioptimus
- Has raised more capital ($76M vs $32M)
- Higher Neuron score (60 vs 42)
- Newer company (2024)
Which should you choose?
Choose Bioptimus if price matters most — it starts at Enterprise · Contact sales, which is friendlier for teams watching burn. Both Drug Discovery tools ship core features, so the cost delta often decides it for small teams and solo operators.
Choose Bioptimus if you want the most established option — it has raised $76M, suggesting more runway for enterprise features, support, and long-term roadmap. For mission-critical workflows or larger teams, that stability often outweighs a lower monthly price.
Frequently asked questions
Alchemab Therapeutics vs Bioptimus — which is better?
It depends on your priority. Alchemab Therapeutics is the leaner option; Bioptimus has broader feature depth. See the side-by-side table above.
Is Alchemab Therapeutics cheaper than Bioptimus?
No — Bioptimus's cheapest paid plan is Enterprise · Contact sales, while Alchemab Therapeutics's is Free.
Do Alchemab Therapeutics and Bioptimus offer free plans?
Alchemab Therapeutics: Yes, has a free plan. Bioptimus: Paid only.
Explore more Drug Discovery tools
Contextual paths to related AI startups, deals and rankings.